News

Filter

Current filters:

Sanofi Pasteur

26 to 35 of 56 results

Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur

12-09-2012

The Dengue Vaccine Initiative (DVI) has welcomed new clinical trial results that reveal progress in developing…

CYD-TDVSanofiSanofi Pasteur

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations

25-07-2012

French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers

21-03-2012

In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

Vivalis opens new lab for antibody discovery; posts 112% revenue hike

25-01-2012

French biotech firm Vivalis (NNYSE Euronext: VLS) says it has opened a new facility for partnered VIVA|Screen…

BiotechnologyEuropeFinancialResearchSanofi PasteurVivalis

Sanofi Pasteur and Vivalis extend MAb accord

19-01-2012

French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

Sanofi Pasteur enters $3 billion acne treatment market in deal with UC San Diego

22-09-2011

Moving into a new therapeutic sector, Sanofi Pasteur, the vaccines division of French drug major Sanofi…

LicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

26 to 35 of 56 results

Back to top